Form 4: Agenus Inc. CEO Garo Armen Receives Stock in Lieu of Cash Salary

A Form 4 filing reveals Agenus Inc. CEO Garo Armen received stock in lieu of cash salary, with additional transactions involving shares held in IRA accounts and through a general partnership.

Summary

• Garo H. Armen, CEO of Agenus Inc., received 1,502 shares of common stock on May 17, 2024, as payment for his salary in lieu of cash.
• The stock was issued at a price of $10.86 per share, which was the closing price of Agenus Inc. common stock on that date.
• Following the transaction, Armen directly owns 72,547 shares.
• Armen also indirectly owns 31,298 shares through his IRA accounts and 28,950 shares as trustee and general partner.
• The shares were issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive and are fully vested on the date of issuance.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO taking stock in lieu of cash could be seen as a positive sign of confidence, but it's also a common practice. The filing itself is a routine disclosure.

Positives

• The CEO's decision to receive stock in lieu of cash may signal confidence in the company's future performance.
• The shares are fully vested upon issuance, aligning the CEO's interests with those of the shareholders.

Industry Context

This type of transaction, where executives receive stock in lieu of cash, is not uncommon in the biotech industry, especially for companies looking to conserve cash or align executive compensation with shareholder value. It's often viewed as a positive sign when executives are willing to take compensation in the form of company stock.

Comparison to Industry Standards

• Comparing this to other biotech companies, executive compensation packages often include a mix of salary, stock options, and restricted stock units.
• For example, executives at companies like Moderna or BioNTech may have similar compensation structures, with a significant portion tied to the company's stock performance.
• The specific amount and type of equity compensation can vary widely based on company size, stage of development, and overall financial health.

Stakeholder Impact

• Shareholders may view the CEO taking stock in lieu of cash as a positive sign, aligning his interests with theirs.
• Employees may see this as a sign of the company's commitment to conserving cash.

Key Dates